Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

L.H. Su, T.L. Wu, C.H. Chiu Clinical Microbiology and Infection

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis.

S. Haessler, A. Paez, M. Rothberg, T. Higgins

L. Boyanova Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

L.H. Su, T.L. Wu, C.H. Chiu Clinical Microbiology and Infection

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

A.K. Reddy, P. Garg, I. Kaur Clinical Microbiology and Infection

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

J.-P. Van geertruyden Clinical Microbiology and Infection

Mcr-1 is borne by highly diverse Escherichia coli isolates since 2004 in food-producing animals in Europe F. El Garch, M. Sauget, D. Hocquet, D. LeChaudee,

Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.

Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H− human isolates from Finland M. Eklund, M. Bielaszewska, U.-M. Nakari,

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Development of 16S rRNA-based probes for the identification of Gram-positive anaerobic cocci isolated from human clinical specimens A.C.M. Wildeboer-Veloo,

Louis Pasteur, from crystals of life to vaccination

Non-antibiotic strategies for sepsis

Prevalence of Toscana virus antibodies in residents of Croatia

Clinical Microbiology and Infection

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Escherichia coli native valve endocarditis

Vector control: a cornerstone in the malaria elimination campaign

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

P. Seng, J.M. Rolain, D. Raoult, P. Brouqui

CMI editorial report 2011 Clinical Microbiology and Infection

Antibiotic resistance patterns of Escherichia coli isolates from different aquatic environmental sources in Leon, Nicaragua E. Amaya, D. Reyes, M. Paniagua,

Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions M. Sjölund, S. Bengtsson, J. Bonnedahl,

G. Pappas Clinical Microbiology and Infection

P. Sidira, H.C. Maltezou, A.-B. Haidich, A. Papa

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Phylogenetic group B2 Escherichia coli strains from the bowel microbiota of Pakistani infants carry few virulence genes and lack the capacity for long-term.

Systematic review of antibiotic consumption in acute care hospitals

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Update on antifungal resistance in Aspergillus and Candida

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Antibacterial drug discovery in the 21st century

Sequence Type ST131 and ST10 Complex (ST617) predominant among CTX-M-15- producing Escherichia coli isolates from Nigeria* I. Aibinu, T. Odugbemi, W.

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

C. Gagliotti, L. Nobilio, M.L. Moro

Prevalence and diversity of extended-spectrum ß-lactamases in faecal Escherichia coli isolates from healthy humans in Spain L. Vinué, Y. Sáenz, S. Martínez,

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

I. Bitar, A. Piazza Clinical Microbiology and Infection

Clinical Microbiology and Infection

Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013 A. Badura, G. Feierl, G. Pregartner,

Survival of rhinoviruses on human fingers

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

L. Zhang, D. Raoult, P.-E. Fournier

O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger

Are we losing the fight against malaria one more time?

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

High prevalence of mutators among Enterobacter cloacae nosocomial isolates and their association with antimicrobial resistance and repetitive detection

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls T. Kudinha, J.R. Johnson, S.D. Andrew, F. Kong, P. Anderson, G.L. Gilbert Clinical Microbiology and Infection Volume 19, Issue 4, Pages E173-E180 (April 2013) DOI: 10.1111/1469-0691.12123 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Distribution of virulence factor (VF) scores among 389 Escherichia coli isolates from men with cystitis or pyelonephritis and healthy controls. The coloured columns indicate, for each source group, the percentage of isolates (y-axis) with a given VF score (x-axis). Median VF scores (range), by group: fecal, 3 (0–13); cystitis 7 (1–14); pyelonephritis 9 (1–16). p values for fecal versus cystitis, fecal versus pyelonephritis, cystitis versus pyelonephritis: p ≤ 0.001 for all comparisons. Clinical Microbiology and Infection 2013 19, E173-E180DOI: (10.1111/1469-0691.12123) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions